tiprankstipranks
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
US Market

Kiora Pharmaceuticals (KPRX) Income Statement

483 Followers

Kiora Pharmaceuticals Income Statement

Last quarter (Q4 2025), Kiora Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kiora Pharmaceuticals's net income was $-6.52M. See Kiora Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 16.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -24.80K$ 16.00M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.43M$ 11.49M$ 12.59M$ 12.31M$ 14.24M
Depreciation and Amortization
$ 24.80K$ 19.20K$ 51.80K$ 41.61K$ 45.30K
EBITDA
$ -9.43M$ 5.70M$ -12.36M$ -13.65M$ -13.91M
Operating Income
$ -9.46M$ 4.51M$ -12.59M$ -12.31M$ -14.24M
Other Income/Expenses
$ -2.66M$ 1.15M$ 163.32K$ -1.39M$ 272.48K
Pretax Income
$ -12.12M$ 5.66M$ -12.42M$ -13.70M$ -13.96M
Net Income
$ -10.84M$ 3.59M$ -12.51M$ -13.58M$ -13.77M
Per Share Metrics
Basic EPS
$ -2.60$ 0.93$ -24.25$ -18.55$ -68.00
Diluted EPS
$ -2.64$ 0.87$ -24.25$ -18.55$ -68.00
Weighted Average Shares Outstanding
4.17M 3.87M 538.01K 732.30K 241.10K
Weighted Average Shares Outstanding (Diluted)
4.10M 4.13M 538.01K 732.30K 241.10K
Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History